TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Lupin Limited ( (IN:LUPIN) ) just unveiled an update.
Lupin Limited has announced the successful passing of resolutions via a postal ballot, including the re-appointment of Mr. Mark D. McDade as an Independent Director and a revision in the remuneration of Managing Director Mr. Nilesh D. Gupta. These resolutions, passed with the requisite majority, reflect the company’s ongoing governance and operational adjustments, potentially impacting its strategic direction and stakeholder relations.
More about Lupin Limited
Lupin Limited is a pharmaceutical company based in Mumbai, India, known for its focus on the development, production, and marketing of a wide range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients globally.
Average Trading Volume: 21,515
Technical Sentiment Signal: Buy
Current Market Cap: 909.5B INR
For a thorough assessment of LUPIN stock, go to TipRanks’ Stock Analysis page.